COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference

February 07, 2023



« back to news page